Rising BioSciences, Inc. (RBII)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Aug 19, 2025
Rising BioSciences Market Cap
Rising BioSciences has a market cap or net worth of $1.06 thousand as of August 25, 2025. Its market cap has decreased by -99.94% in one year.
Market Cap
1.06K
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since December 7, 2018, Rising BioSciences's market cap has decreased from 3.68M to 1.06K, a decrease of -99.97%. That is a compound annual growth rate of -70.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2025 | 1.06K | - |
| Dec 31, 2024 | 1.06K | - |
| Dec 28, 2023 | 1.06K | - |
| Dec 30, 2022 | 1.06K | -99.00% |
| Dec 29, 2021 | 105.97K | -91.67% |
| Dec 31, 2020 | 1.27M | 151.20% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 7, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 632.06M |
| Elite Pharmaceuticals | 587.83M |
| American Oncology Network | 382.44M |
| CytoDyn | 372.33M |
| Northwest Biotherapeutics | 366.64M |